Total Payments
$167.37
2021 Payments
$11.92
Companies
7
Transactions
11
Medicare Patients
1,671
Medicare Billing
$262,369
Payment Breakdown by Category
Food & Beverage$109.98 (65.7%)
Education$57.39 (34.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $109.98 | 7 | 65.7% |
| Education | $57.39 | 4 | 34.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $45.05 | 3 | $0 (2020) |
| Pharmacyclics LLC, An AbbVie Company | $29.48 | 2 | $0 (2018) |
| PFIZER INC. | $25.66 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $23.71 | 1 | $0 (2017) |
| Novocure Inc. | $16.03 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $15.52 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $15.32 | 1 | E.R. Squibb & Sons, L.L.C. ($15.32) |
| 2019 | $30.15 | 2 | Astellas Pharma US Inc ($15.52) |
| 2018 | $57.11 | 4 | Novocure Inc. ($16.03) |
| 2017 | $52.87 | 3 | Janssen Biotech, Inc. ($23.71) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 09/03/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $15.32 | General |
| Category: Oncology | ||||||
| 03/05/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 01/15/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: Oncology | ||||||
| 07/31/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $16.03 | General |
| Category: Optune | ||||||
| 02/20/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
| 10/10/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Oncology | ||||||
| 09/19/2017 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Oncology | ||||||
| 08/01/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 116 | 127 | $21,898 | $7,649 |
| 2021 | 9 | 665 | 1,322 | $263,561 | $90,430 |
| 2020 | 9 | 890 | 2,093 | $466,557 | $164,290 |
Total Patients
1,671
Total Services
3,542
Medicare Billing
$262,369
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 76 | 80 | $11,840 | $4,068 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 40 | 47 | $10,058 | $3,581 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 225 | $67,099 | $23,804 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 191 | 403 | $57,640 | $19,175 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 111 | 234 | $49,320 | $17,732 | 36.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 103 | $16,995 | $5,829 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 121 | $17,903 | $5,797 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 54 | $11,304 | $3,714 | 32.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 41 | 43 | $9,890 | $3,444 | 34.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 34 | 34 | $9,962 | $3,294 | 33.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 30 | $7,080 | $2,439 | 34.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,274 | $1,951 | 37.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 28 | 28 | $5,048 | $1,667 | 33.0% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 15 | 15 | $3,360 | $918.90 | 27.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,686 | $665.76 | 24.8% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Facility | 2020 | 82 | 307 | $121,265 | $48,790 | 40.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 68 | 389 | $97,716 | $33,947 | 34.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 141 | 320 | $56,960 | $18,640 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 209 | 398 | $46,217 | $15,322 | 33.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 121 | $32,219 | $9,532 | 29.6% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 15 | 59 | $23,305 | $9,392 | 40.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 70 | 70 | $20,510 | $6,575 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 139 | $16,369 | $5,255 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 49 | 86 | $14,190 | $4,776 | 33.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 51 | 56 | $12,880 | $4,412 | 34.3% |
About Dr. Shamsher Ali, MD
Dr. Shamsher Ali, MD is a Internal Medicine healthcare provider based in Bridgeport, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1730410499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shamsher Ali, MD has received a total of $167.37 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($109.98).
As a Medicare-enrolled provider, Ali has provided services to 1,671 Medicare beneficiaries, totaling 3,542 services with total Medicare billing of $262,369. Data is available for 3 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Bridgeport, WV
- Active Since 01/20/2010
- Last Updated 04/05/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730410499
Products in Payments
- XTANDI (Drug) $41.18
- OPDIVO (Biological) $31.15
- Imbruvica (Drug) $29.48
- DARZALEX (Biological) $23.71
- Oncology (Device) $16.03
- ELIQUIS (Drug) $13.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bridgeport
Nicholas Dainiak, M.d, M.D
Internal Medicine — Payments: $139,125
Internal Medicine $139,125
Stuart Zarich, M.d, M.D
Internal Medicine — Payments: $94,101
Internal Medicine $94,101
Sanjeev Rao, Md, MD
Internal Medicine — Payments: $33,954
Internal Medicine $33,954
Dr. Joao Nascimento, Md, MD
Internal Medicine — Payments: $30,705
Internal Medicine $30,705
Dr. Charles Rouse, M.d, M.D
Internal Medicine — Payments: $25,586
Internal Medicine $25,586
Dr. Doron Amir, Md, MD
Internal Medicine — Payments: $21,318
Internal Medicine $21,318